View in EDS HTML Full Text PDF Full Text

Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.

Saved in:
Bibliographic Details
Title: Open‐Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.
Authors: Sykes, Andy1 (AUTHOR) andy.sykes@astrazeneca.com, Engman, Helena2 (AUTHOR), Taylor, Nigel3 (AUTHOR), Brier, Tim4 (AUTHOR), Maudsley, Rhiannon5 (AUTHOR), Kirova, Bistra6 (AUTHOR), Mathewson, Alastair M.4 (AUTHOR), Bragg, Ryan A.7 (AUTHOR), Gränfors, Malin8 (AUTHOR), Gangl, Eric T.9 (AUTHOR), Klinowska, Teresa10 (AUTHOR), Li, Yan9 (AUTHOR), Menakuru, Somasekhar R.11 (AUTHOR), Roe, Chris11 (AUTHOR), McDermott, John11 (AUTHOR), Lindemann, Justin P. O.4 (AUTHOR)
Source: CTS: Clinical & Translational Science. Feb2026, Vol. 19 Issue 2, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.70475